Onychomycosis Treatment Guidelines

Introduction to Treatment Options

Onychomycosis is a fungal infection of the nails that can be treated with various topical and oral antifungal agents, with the goal of achieving mycological and clinical cure, as stated by the British Journal of Dermatology guidelines 1, 2
Diagnosis should be confirmed through clinical examination and, if possible, fungal culture or KOH preparation, as recommended by the British Journal of Dermatology guidelines 1

Ciclopirox 8% nail lacquer should be applied once daily for up to 48 weeks for the treatment of onychomycosis, as recommended by the British Journal of Dermatology guidelines 1
Ciclopirox 8% nail lacquer is most appropriate for superficial and distal onychomycosis, as well as patients in whom systemic therapy is contraindicated, based on guidelines from the British Journal of Dermatology 1
Tioconazole 28% solution is applied twice daily for 6-12 months, with side effects including allergic contact dermatitis, and is indicated for superficial and distal onychomycosis, as recommended by the British Journal of Dermatology 1
Amorolfine 5% lacquer is another topical treatment option, with application once or twice weekly for 6-12 months, as per the British Journal of Dermatology guidelines 1
Topical treatments have limited effectiveness due to poor nail plate penetration, hydrophilic nature of nail plate preventing absorption of lipophilic molecules, and high recurrence rates (40-70%) 1, 2

The British Journal of Dermatology recommends oral terbinafine 250mg daily for 12 weeks as the first-line treatment for moderate to severe toenail onychomycosis, with a 70-80% cure rate 1
Terbinafine is significantly more effective than griseofulvin for treating onychomycosis, with cure rates of 70-80% for toenail infections and 80-90% for fingernail infections, as recommended by the British Journal of Dermatology guidelines 1
Itraconazole is recommended if terbinafine is contraindicated, with a pulse therapy regimen of 200 mg twice daily for 1 week per month, and 2 pulses for fingernails or 3 pulses for toenails, as suggested by the British Journal of Dermatology 1
Fluconazole is recommended if terbinafine and itraconazole are contraindicated, with a dosage of 150-450 mg once weekly for 3 months (fingernails) or 6 months (toenails), according to the British Journal of Dermatology guidelines 1
Griseofulvin is no longer a treatment of choice for onychomycosis unless other drugs are unavailable or contraindicated, due to its lower efficacy (30-40% mycological cure rates) and higher risk of drug interactions 1

Combination therapy with oral antifungals may improve outcomes, but concomitant use of ciclopirox 8% and systemic antifungal agents is not specifically recommended due to lack of studies on potential interactions, as stated in the guidelines 1
There is some evidence supporting the combination of ciclopirox with terbinafine as an alternative regimen to continuous terbinafine alone in treating moderate to severe dermatophyte toenail onychomycosis 1
Topical treatment should be part of a comprehensive management program that includes removal of unattached, infected nails as frequently as monthly by a healthcare professional, as recommended by the guidelines 1
Gentle nail debridement/filing of affected areas, treatment of concomitant tinea pedis, and examination of family members for potential sources of infection are important for successful treatment, as stated in the guidelines 1

To prevent recurrence, patients should wear protective footwear in public areas, apply absorbent and antifungal powders in shoes, wear cotton, absorbent socks, keep nails short, and consider discarding old footwear or treating with naphthalene mothballs, as recommended by general medical guidelines and the British Journal of Dermatology 1
Recurrence prevention is important, considering periodic application of topical antifungals to prevent reinfection, as recommended by the British Journal of Dermatology guidelines 1
Inform patients that topical treatments require prolonged use (up to 48 weeks) and complete cure rates are relatively low, as noted in the patient management guidelines 1

Children generally respond better and faster to treatment than adults, with higher cure rates, and always checking for concomitant tinea pedis and examining family members is crucial, as familial disease often occurs, as stated by the British Journal of Dermatology guidelines 1
Systemic antifungal therapy is generally recommended for pediatric onychomycosis due to higher cure rates compared to topical therapy alone, with terbinafine being the first-line option, as recommended by the British Journal of Dermatology guidelines 1
If treatment fails, consider subungual dermatophytoma preventing drug penetration, partial nail removal, trying alternative antifungal agent, or combination therapy, as recommended by the British Journal of Dermatology guidelines 2